SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 5,602.00 |
| Enterprise Value ($M) | 6,142.13 |
| Book Value ($M) | 298.67 |
| Book Value / Share | 4.67 |
| Price / Book | 18.76 |
| NCAV ($M) | -138.47 |
| NCAV / Share | -2.17 |
| Price / NCAV | -40.46 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.07 |
| Return on Assets (ROA) | -0.06 |
| Return on Equity (ROE) | -0.22 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.80 |
| Current Ratio | 2.85 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 742.68 |
| Assets | 1,179.81 |
| Liabilities | 881.15 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 508.82 |
| Operating Income | -212.04 |
| Net Income | -67.09 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -192.59 |
| Cash from Investing | -47.50 |
| Cash from Financing | 273.11 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 8.00 | -22.68 | |
| 13G/A | Fmr Llc | 3.50 | -48.31 | |
| 13G/A | Price T Rowe Associates Inc /md/ | 8.50 | -13.82 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 123,330 | 619,314 | 19.91 | |
| 101,630 | 508,591 | 19.98 | |
| 80,074 | 433,629 | 18.47 | |
| 133,359 | 617,520 | 21.60 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BLUE – bluebird bio, Inc. | BMEA – Biomea Fusion, Inc. |
| BMRN – BioMarin Pharmaceutical Inc. | CABA – Cabaletta Bio, Inc. |
| CCCC – C4 Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io